These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 4201416)

  • 1. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urease activity of bacteria in urine].
    Arai Y; Takeuchi H; Tomoyoshi T; Tatewaki K
    Hinyokika Kiyo; 1989 Feb; 35(2):277-81. PubMed ID: 2500012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of acetohydroxamic acid on the induction of bacterial ureases.
    Rosenstein I; Hamilton-Miller JM; Brumfitt W
    Invest Urol; 1980 Sep; 18(2):112-4. PubMed ID: 6997229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of infected urinary stones by urease inhibition.
    Griffith DP; Musher DM
    Invest Urol; 1973 Nov; 11(3):228-33. PubMed ID: 4584162
    [No Abstract]   [Full Text] [Related]  

  • 5. Urease. The primary cause of infection-induced urinary stones.
    Griffith DP; Musher DM; Itin C
    Invest Urol; 1976 Mar; 13(5):346-50. PubMed ID: 815197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Proteus vulgaris urease by hydroxamic acids.
    Hase J; Kobashi K
    J Biochem; 1967 Sep; 62(3):293-9. PubMed ID: 5586497
    [No Abstract]   [Full Text] [Related]  

  • 7. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones.
    Millner OE; Andersen JA; Appler ME; Benjamin CE; Edwards JG; Humphrey DT; Shearer EM
    J Urol; 1982 Feb; 127(2):346-50. PubMed ID: 7038144
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of urease in the formation of infection stones: comparison of ureases from different sources.
    Rosenstein IJ; Hamilton-Miller JM; Brumfitt W
    Infect Immun; 1981 Apr; 32(1):32-7. PubMed ID: 7012032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benurestat, a urease inhibitor for the therapy of infected ureolysis.
    Andersen JA
    Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms].
    Lorenz J; Lorenz K; Dabrowska B; Kowal R
    Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ureaplasma urealyticum-induced crystallization of magnesium ammonium phosphate and calcium phosphates in synthetic urine.
    Grenabo L; Brorson JE; Hedelin H; Pettersson S
    J Urol; 1984 Oct; 132(4):795-9. PubMed ID: 6381769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus.
    Perrone G; Ferrari C; Arghittu M
    Boll Ist Sieroter Milan; 1982; 61(6):513-5. PubMed ID: 6765400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of urease by hydroxamic acids.
    Gale GR; Atkins LM
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):289-98. PubMed ID: 5348403
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors affecting crystal precipitation from urine in individuals with long-term urinary catheters colonized with urease-positive bacterial species.
    Mathur S; Suller MT; Stickler DJ; Feneley RC
    Urol Res; 2006 Jun; 34(3):173-7. PubMed ID: 16453146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides.
    Torzewska A; Stączek P; Róźalski A
    J Med Microbiol; 2003 Jun; 52(Pt 6):471-477. PubMed ID: 12748265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid.
    Satoh M; Munakata K; Kitoh K; Seto N; Kanazawa T; Takeuchi H; Yoshida O
    J Pharmacobiodyn; 1981 Jul; 4(7):469-74. PubMed ID: 7028944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of infected urinary stones by urease inhibitor. IV. Treatment of infection stones in rats by a new hydroxamic acid and cefalexin].
    Takeuchi H; Tomoyoshi T; Okada Y; Yoshida O; Kobashi K
    Hinyokika Kiyo; 1983 Mar; 29(3):297-302. PubMed ID: 6375315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative.
    Takeuchi H; Kobashi K; Yoshida O
    Invest Urol; 1980 Sep; 18(2):102-5. PubMed ID: 6997228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial agmatine ureohydrolase].
    Khramov VA
    Biokhimiia; 1972; 37(5):922-4. PubMed ID: 4629050
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.